| The economic value of personalized medicine tests: what we know and what we need to know KA Phillips, J Ann Sakowski, J Trosman, MP Douglas, SY Liang, ... Genetics in Medicine 16 (3), 251-257, 2014 | 146 | 2014 |
| Barriers to the use of personalized medicine in breast cancer CB Weldon, JR Trosman, WJ Gradishar, AB Benson III, JC Schink Journal of Oncology Practice 8 (4), e24-e31, 2012 | 88 | 2012 |
| Genomic sequencing: assessing the health care system, policy, and big-data implications KA Phillips, JR Trosman, RK Kelley, MJ Pletcher, MP Douglas, ... Health affairs 33 (7), 1246-1253, 2014 | 77 | 2014 |
| Telehealth in oncology during the COVID-19 outbreak: bringing the house call back virtually R Liu, T Sundaresan, ME Reed, JR Trosman, CB Weldon, T Kolevska JCO Oncology Practice 16 (6), 289-293, 2020 | 71 | 2020 |
| Health technology assessment and private payers' coverage of personalized medicine JR Trosman, SL Van Bebber, KA Phillips Journal of Oncology Practice 7 (3S), 18s-24s, 2011 | 71 | 2011 |
| Health technology assessment and private payers' coverage of personalized medicine JR Trosman, SL Van Bebber, KA Phillips Journal of Oncology Practice 7 (3S), 18s-24s, 2011 | 71 | 2011 |
| Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay JR Trosman, SL Van Bebber, KA Phillips Journal of Oncology Practice 6 (5), 238-242, 2010 | 65 | 2010 |
| Payer coverage policies for multigene tests KA Phillips, PA Deverka, JR Trosman, MP Douglas, JD Chambers, ... Nature biotechnology 35 (7), 614-617, 2017 | 55 | 2017 |
| Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic … JR Trosman, CB Weldon, A Slavotinek, ME Norton, MP Douglas, ... Genetics in medicine 22 (2), 283-291, 2020 | 51 | 2020 |
| Payer coverage for hereditary cancer panels: barriers, opportunities, and implications for the precision medicine initiative JR Trosman, CB Weldon, MP Douglas, AW Kurian, RK Kelley, ... Journal of the National Comprehensive Cancer Network 15 (2), 219-228, 2017 | 49 | 2017 |
| Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in JR Trosman, CB Weldon, RK Kelley, KA Phillips Journal of the National Comprehensive Cancer Network 13 (3), 311-318, 2015 | 47 | 2015 |
| Telemedicine in oncology and reimbursement policy during COVID-19 and beyond SM Kircher, M Mulcahy, A Kalyan, CB Weldon, JR Trosman, AB Benson Journal of the National Comprehensive Cancer Network 19 (13), 11-17, 2020 | 41 | 2020 |
| Care for a patient with cancer as a project: Management of complex task interdependence in cancer care delivery JR Trosman, RC Carlos, MA Simon, DL Madden, WJ Gradishar, ... Journal of oncology practice 12 (11), 1101-1113, 2016 | 36 | 2016 |
| Attitudes and perceptions of multidisciplinary cancer care clinicians toward telehealth and secure messages E Neeman, D Kumar, L Lyon, T Kolevska, M Reed, T Sundaresan, A Arora, ... JAMA network open 4 (11), e2133877-e2133877, 2021 | 35 | 2021 |
| Private payer coverage policies for exome sequencing (ES) in pediatric patients: trends over time and analysis of evidence cited MP Douglas, SL Parker, JR Trosman, AM Slavotinek, KA Phillips Genetics in medicine 21 (1), 152-160, 2019 | 34 | 2019 |
| Availability and payer coverage of BRCA1/2 tests and gene panels E Clain, JR Trosman, MP Douglas, CB Weldon, KA Phillips Nature biotechnology 33 (9), 900-902, 2015 | 27 | 2015 |
| Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers JC Schink, JR Trosman, CB Weldon, KP Siziopikou, GJ Tsongalis, ... Journal of the National Cancer Institute 106 (10), dju256, 2014 | 24 | 2014 |
| Emergence of hybrid models of genetic testing beyond direct-to-consumer or traditional labs KA Phillips, JR Trosman, MP Douglas Jama 321 (24), 2403-2404, 2019 | 23 | 2019 |
| Payer decision making for next-generation sequencing–based genetic tests: insights from cell-free DNA prenatal screening AP Dervan, PA Deverka, JR Trosman, CB Weldon, MP Douglas, ... Genetics in Medicine 19 (5), 559-567, 2017 | 23 | 2017 |
| Decision making on medical innovations in a changing health care environment: Insights from accountable care organizations and payers on personalized medicine and other … JR Trosman, CB Weldon, MP Douglas, PA Deverka, JB Watkins, ... Value in Health 20 (1), 40-46, 2017 | 23 | 2017 |
